162 related articles for article (PubMed ID: 29181103)
1. Myxoid liposarcoma with cartilaginous differentiation showing
Suzuki K; Yasuda T; Watanabe K; Hori T; Kanamori M; Kimura T
Oncol Lett; 2017 Dec; 14(6):6789-6794. PubMed ID: 29181103
[TBL] [Abstract][Full Text] [Related]
2. The utility of fluorescence in situ hybridization (FISH) in the diagnosis of myxoid soft tissue neoplasms.
Downs-Kelly E; Goldblum JR; Patel RM; Weiss SW; Folpe AL; Mertens F; Hartke M; Tubbs RR; Skacel M
Am J Surg Pathol; 2008 Jan; 32(1):8-13. PubMed ID: 18162764
[TBL] [Abstract][Full Text] [Related]
3. Expression of CTAG1B clone EPR13780 versus
Abdelaziz MM; Tayel HY; Abdel-Bary A; Badawy OM
J Histotechnol; 2022 Jun; 45(2):56-65. PubMed ID: 34845972
[TBL] [Abstract][Full Text] [Related]
4. Myxoid liposarcoma with cartilaginous differentiation: A case study with fish analysis and review of the literature.
Ioannou MG; Kouvaras E; Papamichali R; Karachalios T; Koukoulis G
Pathol Res Pract; 2013 Oct; 209(10):666-9. PubMed ID: 23920321
[TBL] [Abstract][Full Text] [Related]
5. DDIT3 gene break-apart as a molecular marker for diagnosis of myxoid liposarcoma--assay validation and clinical experience.
Narendra S; Valente A; Tull J; Zhang S
Diagn Mol Pathol; 2011 Dec; 20(4):218-24. PubMed ID: 22089349
[TBL] [Abstract][Full Text] [Related]
6. Nuclear expression of DDIT3 distinguishes high-grade myxoid liposarcoma from other round cell sarcomas.
Baranov E; Black MA; Fletcher CDM; Charville GW; Hornick JL
Mod Pathol; 2021 Jul; 34(7):1367-1372. PubMed ID: 33731886
[TBL] [Abstract][Full Text] [Related]
7. DNA damage-inducible transcript 3 immunohistochemistry is highly sensitive for the diagnosis of myxoid liposarcoma but care is required in interpreting the significance of focal expression.
Vargas AC; Chan NL; Wong DD; Zaborowski M; Fuchs TL; Ahadi M; Clarkson A; Sioson L; Sheen A; Maclean F; Bonar F; Cheah A; Jones M; Chou A; Gill AJ
Histopathology; 2021 Jul; 79(1):106-116. PubMed ID: 33465826
[TBL] [Abstract][Full Text] [Related]
8. Myxoid liposarcoma-associated EWSR1-DDIT3 selectively represses osteoblastic and chondrocytic transcription in multipotent mesenchymal cells.
Suzuki K; Matsui Y; Higashimoto M; Kawaguchi Y; Seki S; Motomura H; Hori T; Yahara Y; Kanamori M; Kimura T
PLoS One; 2012; 7(5):e36682. PubMed ID: 22570737
[TBL] [Abstract][Full Text] [Related]
9. Myxoid Liposarcoma with Cartilagenous Differentiation.
Tariq H; Sarfraz T; Saeed I
J Coll Physicians Surg Pak; 2020 Oct; 30(10):1096-1098. PubMed ID: 33143836
[TBL] [Abstract][Full Text] [Related]
10. Primary Pulmonary Myxoid Liposarcoma with Translocation t(12;16)(q13;p11) in a Young Female Patient: A Brief Case Report.
Son C; Choi PJ; Roh MS
Korean J Pathol; 2012 Aug; 46(4):392-4. PubMed ID: 23110035
[TBL] [Abstract][Full Text] [Related]
11. FUS-DDIT3 Fusion Protein-Driven IGF-IR Signaling is a Therapeutic Target in Myxoid Liposarcoma.
Trautmann M; Menzel J; Bertling C; Cyra M; Isfort I; Steinestel K; Elges S; Grünewald I; Altvater B; Rossig C; Fröhling S; Hafner S; Simmet T; Åman P; Wardelmann E; Huss S; Hartmann W
Clin Cancer Res; 2017 Oct; 23(20):6227-6238. PubMed ID: 28637688
[No Abstract] [Full Text] [Related]
12. Myxoid liposarcoma with cartilaginous differentiation: a case study with cytogenetical analysis.
Kim H; Hwangbo W; Ahn S; Kim S; Kim I; Kim CH
Korean J Pathol; 2013 Jun; 47(3):284-8. PubMed ID: 23837023
[TBL] [Abstract][Full Text] [Related]
13. Detection of myxoid liposarcoma-associated FUS-DDIT3 rearrangement variants including a newly identified breakpoint using an optimized RT-PCR assay.
Powers MP; Wang WL; Hernandez VS; Patel KS; Lev DC; Lazar AJ; López-Terrada DH
Mod Pathol; 2010 Oct; 23(10):1307-15. PubMed ID: 20581806
[TBL] [Abstract][Full Text] [Related]
14. Myxoid liposarcoma with pleomorphic cells: Report of two cases with molecular confirmation of FUS gene rearrangements.
Uchihashi K; Matsuyama A; Nakayama M; Sakamoto A; Shiba E; Hisaoka M
Pathol Res Pract; 2016 Nov; 212(11):1067-1070. PubMed ID: 27515548
[TBL] [Abstract][Full Text] [Related]
15. Relevance of translocation type in myxoid liposarcoma and identification of a novel EWSR1-DDIT3 fusion.
Bode-Lesniewska B; Frigerio S; Exner U; Abdou MT; Moch H; Zimmermann DR
Genes Chromosomes Cancer; 2007 Nov; 46(11):961-71. PubMed ID: 17647282
[TBL] [Abstract][Full Text] [Related]
16. Establishment and characterization of two novel patient-derived myxoid liposarcoma cell lines.
Noguchi R; Yoshimatsu Y; Sin Y; Tsuchiya R; Ono T; Akiyama T; Hirabayashi K; Ozawa I; Nakagawa R; Kikuta K; Kondo T
Hum Cell; 2022 Jul; 35(4):1279-1289. PubMed ID: 35637403
[TBL] [Abstract][Full Text] [Related]
17. The myxoid/round cell liposarcoma fusion oncogene FUS-DDIT3 and the normal DDIT3 induce a liposarcoma phenotype in transfected human fibrosarcoma cells.
Engström K; Willén H; Kåbjörn-Gustafsson C; Andersson C; Olsson M; Göransson M; Järnum S; Olofsson A; Warnhammar E; Aman P
Am J Pathol; 2006 May; 168(5):1642-53. PubMed ID: 16651630
[TBL] [Abstract][Full Text] [Related]
18. FUS-DDIT3 Fusion Oncoprotein Expression Affects JAK-STAT Signaling in Myxoid Liposarcoma.
Dolatabadi S; Jonasson E; Andersson L; Luna Santamaría M; Lindén M; Österlund T; Åman P; Ståhlberg A
Front Oncol; 2022; 12():816894. PubMed ID: 35186752
[TBL] [Abstract][Full Text] [Related]
19. Metastasis of myxoid liposarcoma to fat-bearing areas: A case report of unusual metastatic sites and a hypothesis.
Lin S; Gan Z; Han K; Yao Y; Min D
Oncol Lett; 2015 Oct; 10(4):2543-2546. PubMed ID: 26622886
[TBL] [Abstract][Full Text] [Related]
20. A Patient with Myxoid/Round Cell Liposarcoma (MRCL) Involving the Well-known Translocation t(12;22): A Case Report with the Cytogenomic Landscape of this Rearrangement.
Tirado CA; Su W; Chia V; Zaki M; Tang R; Eastwood K; Guardiola MT; Rao A
J Assoc Genet Technol; 2022; 48(2):68-75. PubMed ID: 35660675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
